EUVIMED · CrossrefZeitschrift
Critical Finance Review
ISSN 2164-5744 · Emerald
Neueste Artikel
Is the Value Premium Smaller Than We Thought?
Selection Bias or Treatment Effect? A Re-Examination of Russell 1000/2000 Index Reconstitution
Identification Using Russell 1000/2000 Index Assignments: A Discussion of Methodologies
Is Economics Research Replicable? Sixty Published Papers From Thirteen Journals Say “Often Not”
Open Source Cross-Sectional Asset Pricing
Intangible Value
Explaining the Recent Failure of Value Investing
Diseconomies of Scale in Active Management: Robust Evidence
Rest in Peace Post-Earnings Announcement Drift
It Could Be Overreaction, Not Lottery Seeking, That Is Behind Bali, Cakici and Whitelaw’s Max Effect
Inflation Bets or Deflation Hedges? The Changing Risks of Nominal Bonds
The Carry Trade: Risks and Drawdowns
Seasonal Variation in Treasury Returns
The Cross-section of Expected Stock Returns
Corporate Debt Maturity and the Real Effects of the 2007 Credit Crisis
Testing Factor-Model Explanations of Market Anomalies
An Empirical Evaluation of the Long-Run Risks Model for Asset Prices
Dominated ETFs
Editorial
Model Before Measurement
Dynamic Corporate Finance is Useful: A Comment on Welch (2013)
Editor’s Letter by Michael Weisbach
Capital Structure Choices
The Long-Run Risks Model and Aggregate Asset Prices: An Empirical Assessment
A Critique of Recent Quantitative and Deep-Structure Modeling in Capital Structure Research and Beyond
Should Benchmark Indices Have Alpha? Revisiting Performance Evaluation
The Housing Wealth Effect: The Crucial Roles of Demographics, Wealth Distribution and Wealth Shares
Wealth Effects Revisited 1975–2012
Model Before Measurement
Dynamic Corporate Finance is Useful: A Comment on Welch (2013)
EUVIMED